
News – Page 11
-
Ten Injuries and One Death Lead to Medtronic Brain Stent RecallIn February 2020, Medtronic recalled 1,812 units of its Pipeline Flex Embolization Device and Pipeline Flex Embolization Device with Shield Technology after…
-
Medtronic Recalls Heart Pumps After Patient DeathMedtronic issued a recall in January 2020 for thousands of HeartWare HVAD System Battery Chargers used with the HeartWare HVAD system after…Michelle Llamas, BCPA July 6, 2020
-
Rheumatoid Arthritis Drug Methotrexate Linked to Increased Skin Cancer RiskA double-blind, placebo-controlled, randomized clinical trial funded by the National Institutes of Health linked low-dose methotrexate to an increased risk of skin…Michelle Llamas, BCPA June 22, 2020
-
Johnson & Johnson Stops Selling Talc-Based Baby Powder in U.S.Johnson & Johnson announced Tuesday that it will permanently discontinue its talc-based Johnson’s Baby Powder in the U.S. and Canada. The company cited…Emily Miller May 20, 2020
-
DOJ, 3M Crack Down on COVID-19 Price GougingA New York man became the first person federally charged with hoarding and reselling tons of “COVID-19 essentials” at a huge markup,…Michelle Llamas, BCPA May 12, 2020
-
Talcum Powder & Ovarian Cancer Lawsuits: A Q&A with Trial Attorney Trent MiracleJohnson & Johnson is facing more than 16,500 talcum powder lawsuits consolidated in a multidistrict litigation, or MDL, in New Jersey federal court,…Michelle Llamas, BCPA May 11, 2020
-
COVID-19-Related Class Action Lawsuits on the RiseAs COVID-19 case numbers climb across the United States, so do the numbers of class action lawsuits for consumer fraud, misleading…Michelle Llamas, BCPA April 29, 2020
-
Vetting a COVID-19 Drug: A Q&A with Immunologist Dr. Hooman NoorchashmAs the global count of COVID-19 cases continues to climb, researchers, scientists and drug makers are working quickly to find a potential treatment.Michelle Llamas, BCPA April 28, 2020
-
Chlorthalidone Linked to Higher Risk of Electrolyte, Kidney ProblemsChlorthalidone — known by the brand name Thalitone — is the American College of Cardiology and American Heart Association’s preferred first-line treatment…Michelle Llamas, BCPA April 20, 2020
Who Am I Calling?
Calling this number connects you with a Drugwatch representative. We will direct you to one of our trusted legal partners for a free case review.
Drugwatch's trusted legal partners support the organization's mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.
(888) 645-1617